Why People Stop Using Drugs Like Ozempic
Drugs like semaglutide—better known as Ozempic or Wegovy—could be lifelong treatments for obesity, but what little data scientists have suggests that people don’t stick with them for long.
Related Articles
Frontiers | Confirmation bias and quantitative approach in psychiatry: should ideological competing interests be declared?
1 ADDIPSY, Outpatient Addictology and Psychiatry Center, Sant é Basque D é veloppement Group, Lyon, France 2 Universit é Paris-Saclay, Universit é de Versailles Saint-Quentin-en-Yvelines…
Warning over ‘severe’ weight-loss jab side effects
Semaglutide and liraglutide are sold under the brand names Wegovy, Ozempic, Rybelsus and Saxenda and are manufactured by Novo Nordisk
USPSTF Recommendation: Screening for Breast Cancer
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
USPSTF Recommendation: Screening for Breast Cancer
This 2024 Recommendation Statement from the US Preventive Services Task Force recommends biennial screening mammography for women aged 40 to 74 years (B recommendation) and…
Digital playtime can be good for children’s well-being, major new report from University of Sheffield finds
Video games used during play can benefit children’s well-being, if designed with their needs in mind, a new study from the University of Sheffield, LEGO…
Numeracy does not polarize climate change judgments: Numerate people are more knowledgeable and knowledge is power.
Statistical numeracy skills have been found to be among the most robust general predictors of risk understanding and decision-making quality. However, some research suggests that…
A fragmented field: Construct and measure proliferation in psychology
We examined the extent to which constructs and measures have proliferated in psychological sci-ence. We integrated two large databases obtained from the American Psychology Association…
Corporate Influences on Science and Health—the Case of Spinal Cord Stimulation
This Viewpoint discusses tactics by corporations to criticize scientific research that may be unfavorable to their industries, recently including the spinal cord stimulator industry.
What’s wrong with the WHO?
The World Health Organization spreads misinformation about e-cigarettes, to the detriment of millions of smokers who could use them to…